377 related articles for article (PubMed ID: 20863907)
1. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.
Galluccio F; Matucci-Cerinic M
Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907
[TBL] [Abstract][Full Text] [Related]
2. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
3. Ulnar artery involvement in systemic sclerosis (scleroderma).
Taylor MH; McFadden JA; Bolster MB; Silver RM
J Rheumatol; 2002 Jan; 29(1):102-6. PubMed ID: 11824945
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.
Sunderkötter C; Riemekasten G
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831
[TBL] [Abstract][Full Text] [Related]
5. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
6. Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon.
Furspan PB; Chatterjee S; Mayes MD; Freedman RR
Rheumatology (Oxford); 2005 Apr; 44(4):488-94. PubMed ID: 15695304
[TBL] [Abstract][Full Text] [Related]
7. Raynaud, digital ulcers and calcinosis in scleroderma.
Nitsche A
Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
[TBL] [Abstract][Full Text] [Related]
8. Digital ulcers: overt vascular disease in systemic sclerosis.
Steen V; Denton CP; Pope JE; Matucci-Cerinic M
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
[TBL] [Abstract][Full Text] [Related]
9. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
[TBL] [Abstract][Full Text] [Related]
10. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
[TBL] [Abstract][Full Text] [Related]
11. Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study.
Kawald A; Burmester GR; Huscher D; Sunderkötter C; Riemekasten G
J Rheumatol; 2008 Sep; 35(9):1830-7. PubMed ID: 18634152
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
13. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
Yocum DE; Hodes R; Sundstrom WR; Cleeland CS
J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
[TBL] [Abstract][Full Text] [Related]
14. Implications of endothelial shear stress on systemic sclerosis vasculopathy and treatment.
Frech TM; Machin DR; Murtaugh MA; Stoddard GJ; Bloom SI; Phibbs JV; Donato AJ
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):175-182. PubMed ID: 30277867
[TBL] [Abstract][Full Text] [Related]
15. Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors.
Sunderkötter C; Herrgott I; Brückner C; Moinzadeh P; Pfeiffer C; Gerss J; Hunzelmann N; Böhm M; Krieg T; Müller-Ladner U; Genth E; Schulze-Lohoff E; Meurer M; Melchers I; Riemekasten G;
Br J Dermatol; 2009 Apr; 160(4):835-43. PubMed ID: 19183180
[TBL] [Abstract][Full Text] [Related]
16. Digital thermal hyperaemia impairment does not relate to skin fibrosis or macrovascular disease in systemic sclerosis.
Salvat-Melis M; Carpentier PH; Minson CT; Boignard A; McCord GR; Paris A; Moreau-Gaudry A; Cracowski JL
Rheumatology (Oxford); 2006 Dec; 45(12):1490-6. PubMed ID: 16705051
[TBL] [Abstract][Full Text] [Related]
17. Raynaud's phenomenon and systemic sclerosis.
Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options for digital ulcers in patients with systemic sclerosis.
Chung L
J Dtsch Dermatol Ges; 2007 Jun; 5(6):460-5. PubMed ID: 17537038
[TBL] [Abstract][Full Text] [Related]
19. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of digital ulcers in a scleroderma patient with continuous bilateral thoracic sympathetic block.
Han KR; Kim C; Park EJ
Pain Physician; 2008 Jan; 11(1):91-6. PubMed ID: 18196175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
